Paper6563941
Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
de Jong WH and 6 others. Cancer Immunol Immunother, 1984. Cited by 23 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches. Papers, record 6563941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6563941
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BCG Vaccine | Major topic |
| Alanine Transaminase | |
| Animals | |
| Body Temperature | |
| Carcinoma, Squamous Cell | |
| Cell Line | |
| Dose-Response Relationship, Immunologic | |
| Evaluation Studies as Topic | |
| Female | |
| Hypersensitivity, Delayed | |
| Immunization | |
| Killer Cells, Natural | |
| Liver Neoplasms, Experimental | |
| Lung Neoplasms | |
| Lymph Nodes | |
| Lymphoma | |
| Macrophages | |
| Mice | |
| Neoplasms | |
| Organ Size | |
| Rabbits | |
| Skin Tests | |
| Spleen |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 283275 | In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/283275 | PubMed |
| 3 | 7466726 | Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma. | Thorax | 1980 | https://conductscience.org/library/papers/7466726 | PubMed |
| 4 | 447557 | Immunotherapy in ocular equine sarcoid. | J Am Vet Med Assoc | 1979 | https://conductscience.org/library/papers/447557 | PubMed |
| 5 | 7407781 | Use of new biologic agents in clinical immunotherapy. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7407781 | PubMed |
| 6 | 7046801 | Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system. | Biochim Biophys Acta | 1982 | https://conductscience.org/library/papers/7046801 | PubMed |
| 7 | 7330812 | Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth. | Thorax | 1981 | https://conductscience.org/library/papers/7330812 | PubMed |
| 8 | 608553 | Proposals for quality control methods of bacterial vaccines for immunostimulation. II. In vivo and in vitro stimulation of lymphocytes by BCG. | Dev Biol Stand | 1977 | https://conductscience.org/library/papers/608553 | PubMed |
| 9 | 864757 | Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine. | J Natl Cancer Inst | 1977 | https://conductscience.org/library/papers/864757 | PubMed |
| 10 | 288936 | Quantitative comparison of BCG strains and preparations in immunotherapy of a rat sarcoma. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/288936 | PubMed |
| 11 | 348035 | Immunotherapy from malignant disease. | Annu Rev Med | 1978 | https://conductscience.org/library/papers/348035 | PubMed |
| 12 | 6210637 | Mechanisms of action of Mycobacterium bovis BCG-induced suppressor cells in mitogen-induced blastogenesis. | Infect Immun | 1982 | https://conductscience.org/library/papers/6210637 | PubMed |
| 13 | 13909847 | [Immunological studies with Haemaccel]. | Dtsch Med Wochenschr | 1962 | https://conductscience.org/library/papers/13909847 | PubMed |
| 14 | 6845257 | Intrapleural Corynebacterium parvum for malignant pleural effusions. | Thorax | 1983 | https://conductscience.org/library/papers/6845257 | PubMed |
| 15 | 13995378 | Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability. | Br Med J | 1962 | https://conductscience.org/library/papers/13995378 | PubMed |
| 16 | 7029149 | Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group. | J Thorac Cardiovasc Surg | 1981 | https://conductscience.org/library/papers/7029149 | PubMed |
| 17 | 4587143 | Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4587143 | PubMed |
| 18 | 4373753 | Differential effects of two strains of BCG on transplantation immunity to SV40-induced tumors in hamsters. | Proc Soc Exp Biol Med | 1974 | https://conductscience.org/library/papers/4373753 | PubMed |
| 19 | 6928226 | Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity. | J Natl Cancer Inst | 1980 | https://conductscience.org/library/papers/6928226 | PubMed |
| 20 | 6344747 | Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. | Ann Immunol (Paris) | 1983 | https://conductscience.org/library/papers/6344747 | PubMed |
| 21 | 6563941 | Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6563941 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6563941 | Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6563941 | PubMed |
| 3787886 | The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder. | Urol Res | 1986 | https://conductscience.org/library/papers/3787886 | PubMed |
| 3633215 | Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3633215 | PubMed |
| 2922891 | Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig. | Urol Res | 1989 | https://conductscience.org/library/papers/2922891 | PubMed |
| 2376047 | Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2376047 | PubMed |
| 2337907 | Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guérin. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2337907 | PubMed |
| 2199369 | Increased activity of FIM in serum of mice during a Mycobacterium bovis (BCG) infection. | Immunology | 1990 | https://conductscience.org/library/papers/2199369 | PubMed |
| 1828389 | Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1828389 | PubMed |
| 1760813 | Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1760813 | PubMed |
| 1756535 | Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1756535 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6563941
GET https://conductscience.org/api/papers/v1/6563941/references?page=2